SCHEMBL29520844

SCHEMBL29520844

CC(C)C1=CC2=CC[C@@H]3[C@](C)(CCC[C@@]3(C)C(=O)OCC(CO)(CO)CO)[C@H]2CC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 3/20 0.67
▸ ALOX15 P16050 3/20 0.67
▸ PDK1 Q15118 2/20 0.67
▸ PDK2 Q15119 2/20 0.67
▸ PDK3 Q15120 2/20 0.67
▸ PDK4 Q16654 2/20 0.67
▸ LMNA P02545 2/20 0.67
▸ ALDH1A1 P00352 2/20 0.67
▸ CYP3A4 P08684 2/20 0.67
▸ MAPT P10636 2/20 0.67
▸ SLCO1B3 Q9NPD5 1/20 0.67
▸ SLCO1B1 Q9Y6L6 1/20 0.67
▸ GABRA1 P14867 1/20 0.67
▸ GABRB2 P47870 1/20 0.67
▸ CYP2C9 P11712 1/20 0.67
▸ CYP2C19 P33261 1/20 0.67
▸ KDM4E B2RXH2 1/20 0.67
▸ MAPK1 P28482 2/20 0.60
▸ MEN1 O00255 2/20 0.53
▸ KMT2A Q03164 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3615621 1.00 HSD17B10 (0.67) HSD17B10ALOX15PDK1PDK2PDK3
SCHEMBL13337972 0.95 HSD17B10 (0.71) HSD17B10ALOX15PDK1PDK2PDK3
SCHEMBL30254089 0.95 HSD17B10 (0.71) HSD17B10ALOX15PDK1PDK2PDK3
SCHEMBL13366510 0.89 HSD17B10 (0.63) HSD17B10ALOX15PDK1PDK2PDK3
SCHEMBL770009 0.88 HSD17B10 (0.71) HSD17B10ALOX15PDK1PDK2PDK3
SCHEMBL770010 0.88 HSD17B10 (0.71) HSD17B10ALOX15PDK1PDK2PDK3
SCHEMBL14495336 0.88 HSD17B10 (0.71) HSD17B10ALOX15PDK1PDK2PDK3
SCHEMBL2418156 0.88 HSD17B10 (0.74) HSD17B10ALOX15PDK1PDK2PDK3
SCHEMBL2418158 0.88 HSD17B10 (0.74) HSD17B10ALOX15PDK1PDK2PDK3
SCHEMBL13337971 0.88 HSD17B10 (0.74) HSD17B10ALOX15PDK1PDK2PDK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025071300-A1 TWO-PHASE COMPOSITION COMPRISING DIPHENYL DIMETHICONE AND ROSINATE OIL 주식회사 엘지생활건강 2025-04-03 — — WO claimed
US-20250064711-A1 COSMETIC COMPOSITION COMPRISING A POLYHYDROXYALKANOATE COPOLYMER BEARING A(N) (UN)SATURATED HYDROCARBON-BASED CHAIN AND A NATURAL RESIN L'OREAL (FR) 2025-02-27 — — US claimed
EP-4452418-A1 COSMETIC COMPOSITION COMPRISING A POLYHYDROXYALKANOATE COPOLYMER BEARING A(N) (UN)SATURATED HYDROCARBON-BASED CHAIN AND A NATURAL RESIN L'OREAL (FR) 2024-10-30 — — EP claimed
WO-2023163457-A1 METHOD FOR PREPARING COMPOSITE POWDER SURFACE TREATED WITH NATURALLY DERIVED RESIN AND COSMETIC COMPOSITION CONTAINING COMPOSITE POWDER PREPARED THEREBY 주식회사 코스메카코리아 2023-08-31 — — WO claimed
WO-2023118529-A1 COSMETIC COMPOSITION COMPRISING A POLYHYDROXYALKANOATE COPOLYMER BEARING A(N) (UN)SATURATED HYDROCARBON-BASED CHAIN AND A NATURAL RESIN L'OREAL (FR) 2023-06-29 — — WO claimed
EP-4731172-A2 COSMETIC COMPOSITION COMPRISING AT LEAST ONE NATURAL RESIN AND A CRYSTALLIZABLE FATTY SUBSTANCE L'OREAL (FR) 2026-04-29 — — EP disclosed
EP-4731169-A1 COMPOSITION WITH CHITOSAN AND A NATURAL RESIN L'OREAL (FR) 2026-04-29 — — EP disclosed
US-20260060916-A1 OIL-BASED COSMETIC TOMBOW PENCIL CO., LTD. (JP) 2026-03-05 — — US disclosed
EP-4618937-A1 MASCARA FORMULATION Coty Inc. (US) 2025-09-24 — — EP disclosed
US-20250222245-A1 SEMI-PERMANENT TATTOO TRANSFER DEVICES AND IMAGE-FORMING COMPOSITIONS TMI Acquisition, LLC 2025-07-10 — — US disclosed
US-20250213441-A1 Cosmetic Composition Comprising a Natural Resin L'OREAL (FR) 2025-07-03 — — US disclosed
WO-2025119795-A1 MAKEUP COMPOSITION COMPRISING A NATURAL RESIN, OPTIONALLY A CELLULOSE ETHER, A PARTICULAR POLYESTER AND VOLATILE COMPOUNDS, AND PROCESS L'OREAL (FR) 2025-06-12 — — WO disclosed
WO-2023118430-A1 COSMETIC COMPOSITION COMPRISING A NATURAL RESIN L'OREAL (FR) 2023-06-29 — — WO disclosed
WO-2023118529-A1 COSMETIC COMPOSITION COMPRISING A POLYHYDROXYALKANOATE COPOLYMER BEARING A(N) (UN)SATURATED HYDROCARBON-BASED CHAIN AND A NATURAL RESIN L'OREAL (FR) 2023-06-29 — — WO disclosed
US-20230157299-A1 DISPENSABLE NANOPARTICLE BASED COMPOSITION FOR DISINFECTION KISMET TECHNOLOGIES INC. 2023-05-25 — — US disclosed
EP-4164963-A2 PACKAGES COMPRISING ANTI-MICROBIAL COATINGS FOR PREVENTING CONTAMINATION, E.G. AFTER FIRST USE OF THE PRODUCT SiO2 Medical Products, Inc. (US) 2023-04-19 — — EP disclosed
EP-3296308-B1 DEXTRIN FATTY ACID ESTER AND COSMETIC CHIBA FLOUR MILLING (JP) 2023-03-29 — — EP disclosed
EP-4125364-A1 DISPENSABLE NANOPARTICLE BASED COMPOSITION FOR DISINFECTION University of Central Florida Research Foundation, Inc. (US) 2023-02-08 — — EP disclosed
JP-2022081371-A HAIRDRESSING COMPOSITION 株式会社マンダム 2022-05-31 — — JP disclosed
WO-2021257728-A9 PACKAGES COMPRISING ANTI-MICROBIAL COATINGS FOR PREVENTING CONTAMINATION, E.G. AFTER FIRST USE OF THE PRODUCT SIO2 MEDICAL PRODUCTS, INC. (US) 2022-03-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250213441-A1 Cosmetic Composition Comprising a Natural Resin KRT18, CUTA, EPCAM HSD17B10 1433/4885ALOX15 898/4885PDK1 4188/4885
US-20230157299-A1 DISPENSABLE NANOPARTICLE BASED COMPOSITION FOR DISINFECTION DSTN, CD63, EXOSC9 HSD17B10 3750/4885ALOX15 1802/4885PDK1 4294/4885
US-20250064711-A1 COSMETIC COMPOSITION COMPRISING A POLYHYDROXYALKANOATE COPOLYMER BEARING A(N) (UN)SATURATED HYDROCARBON-BASED CHAIN AND A NATURAL RESIN HCAR3, RARA, HCAR1 HSD17B10 154/4885ALOX15 290/4885PDK1 4444/4885
US-20260060916-A1 OIL-BASED COSMETIC ATM, TAOK2, TAF9 HSD17B10 3698/4885ALOX15 1057/4885PDK1 2622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback